Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

October

4

OrthoSensor Announces Milestone of 50,000 VeraSense™ Sensors Distributed Globally

10/04/2018 VERASENSE is transforming primary and revision total knee replacement for surgeons and patients...

2

Exagen Featured in Eight Scientific Presentations at the 2018 ACR/ARHP Annual Meeting in Chicago

Leading immunology laboratory continues strides with first ever economic impact data for AVISE Lupus...

27

AlphaTec Accelerates Organic Innovation Machine with Addition of Key Senior Leadership and Expansion of Market

Mark Ojeda to lead Cervical and Biologics CARLSBAD, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) — Alphatec Holdings,...

26

AlphaTec Advances Clinical Distinction with OsseoCrew® Clearance

Alphatec’s OsseoScrew® System received 510(k) clearance from the U.S. Food & Drug Administration (FDA), making it available for clinical...

12

SureFire Medical to Change Name to TriSalus Life Sciences

New company name better represents contribution to patient care DENVER, Sept. 12, 2018 – Surefire...

11

Exagen, Maker of Avise Testing, Announces First Blood Test for AntiCarp, a Breakthrough Biomarker for Rheumatoid Arthritis

Novel test now available to aid in detection and management of widespread debilitating condition...

5

SupplyPro Delivers Absolute Accountability with SupplyStream Scale Module™

SupplySystem Scale Module Provides Automated Weight-Based Dispensing with Managed Accountability SAN DIEGO – September...

13

FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters

Midazolam Nasal Spray has been granted orphan drug designation by the United States Food...

9

ElectroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-invasive Vagus Nerve Stimulation in Neuroinflammation

Non-invasive vagus nerve stimulation (nVNS) will be studied in preclinical settings, looking at the...

1

Next Generation NVNS Therapy GammaCore Sapphire™ Now Available For Patients with Migraine an Episodic Cluster Headache in United States

Innovative technology provides patients with convenient, easy-to-use treatment option without the potential side effects...

17

ElectroCore and UpScript Launch Program to Offfer Direct-To-Patient Telemedicine Option For GammaCore™ in the United States

gammaCore is the first FDA-cleared, nVNS therapy that can be self-administered by patients as...

13

New Research Shows Promise in Regional Deliver of CAR-T Therapy

Authors conclude delivery devices should be developed in conjunction with CAR-T therapies DENVER–(BUSINESS WIRE)–Surefire...

Recent developments

News

October

4

OrthoSensor Announces Milestone of 50,000 VeraSense™ Sensors Distributed Globally

October

2

Exagen Featured in Eight Scientific Presentations at the 2018 ACR/ARHP Annual Meeting in Chicago

September

27

AlphaTec Accelerates Organic Innovation Machine with Addition of Key Senior Leadership and Expansion of Market

September

26

AlphaTec Advances Clinical Distinction with OsseoCrew® Clearance

September

12

SureFire Medical to Change Name to TriSalus Life Sciences

September

11

Exagen, Maker of Avise Testing, Announces First Blood Test for AntiCarp, a Breakthrough Biomarker for Rheumatoid Arthritis

September

5

SupplyPro Delivers Absolute Accountability with SupplyStream Scale Module™

August

13

FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters

August

9

ElectroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-invasive Vagus Nerve Stimulation in Neuroinflammation

August

1

Next Generation NVNS Therapy GammaCore Sapphire™ Now Available For Patients with Migraine an Episodic Cluster Headache in United States

July

17

ElectroCore and UpScript Launch Program to Offfer Direct-To-Patient Telemedicine Option For GammaCore™ in the United States

July

13

New Research Shows Promise in Regional Deliver of CAR-T Therapy